Idarucizumab before reperfusion therapy in stroke patients on dabigatran: No more cold sweat

Affiliations

¹ From Stroke Service (F.A.D., O.M.P.-N.), Neurology Division, Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; and Department of Neurology (D.J.S.), University Hospital Bern, Inselspital, University of Bern, Switzerland. franciscodias.neuro@usp.br.
² From Stroke Service (F.A.D., O.M.P.-N.), Neurology Division, Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; and Department of Neurology (D.J.S.), University Hospital Bern, Inselspital, University of Bern, Switzerland.

Editorial

Francisco A Dias et al. Neurology. 2020.

. 2020 May 12;94(19):811-812.

doi: 10.1212/WNL.0000000000009156. Epub 2020 Feb 20.

¹ From Stroke Service (F.A.D., O.M.P.-N.), Neurology Division, Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; and Department of Neurology (D.J.S.), University Hospital Bern, Inselspital, University of Bern, Switzerland. franciscodias.neuro@usp.br.
² From Stroke Service (F.A.D., O.M.P.-N.), Neurology Division, Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; and Department of Neurology (D.J.S.), University Hospital Bern, Inselspital, University of Bern, Switzerland.

No abstract available

Comment on

Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort.
Barber PA, Wu TY, Ranta A. Barber PA, et al. Neurology. 2020 May 12;94(19):e1968-e1972. doi: 10.1212/WNL.0000000000009155. Epub 2020 Feb 20. Neurology. 2020. PMID: 32079737